Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effectiveness of Mind-Body Intervention for Inflammatory Conditions: Results from a 26-Week Randomized, Non-Blinded, Parallel-Group Trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Defining NASH from a multi-omics systems biology perspective

    Research output: Contribution to journalReviewResearchpeer-review

  2. Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Biomarkers of subclinical atherosclerosis in patients with psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comparison of Cytokines in Skin Biopsies and Tape Strips from Adults with Atopic Dermatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The role of interleukin-1β in the immune response to contact allergens

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Biopsychosocial intervention has been suggested as a complementary treatment strategy for patients with chronic conditions. We compared the effect of a mind-body intervention (MBI), relative to treatment-as-usual (TAU) on WHO-5 Well-being Index during an intensive period of 12 weeks and follow-up at week 26 among patients with either psoriasis (PsO) or rheumatoid arthritis (RA). The MBI was based on the 'Relaxation Response Resiliency Program' and the 'Open and Calm Program', as well as 'Mindfulness Based Stress Reduction' (MBSR). The trial was randomized, management-as-usual, and controlled. Statistical analyses were based on the intention-to-treat population using repeated measures and mixed effects models (NCT03888261). We screened 39 potential participants, 35 of which (PsO, n = 20; RA, n = 15) met the eligibility criteria and were randomized: 17 in the MBI group and 18 in the TAU group. Attrition from the intervention program was 19%, with 65% of MBI patients and 71% of TAU patients completing the outcome assessments. After 12 weeks, a statistically significant difference in WHO-5 was observed between the groups (p = 0.019). However, according to the protocol, during the entire trial period, the average (least squares mean values) WHO-5 score was higher although not statistically significant in the MBI group (65.3) compared with the TAU group (59.1), corresponding to a between-group difference over 26 weeks of 6.15 (95% CI: -0.26 to 12.56; p = 0.060). All things considered, adding biopsychosocial intervention to clinical practice to patients with conditions, such as PsO and RA, could potentially improve health-related quality of life.

Original languageEnglish
Article number3107
JournalJournal of Clinical Medicine
Volume10
Issue number14
ISSN2077-0383
DOIs
Publication statusPublished - 14 Jul 2021

    Research areas

  • biopsychosocial, health-related quality of life, mind-body intervention, psoriasis, rheumatoid arthritis, treatment-as-usual

ID: 67397295